Graham DJ, Ouellet-Hellstrom R, MaCurdy TE, Ali F, Sholley C, Worrall C, et al
Clinical observations suggest that patients combining these therapies often experience more stable blood sugar fluctuations and more sustainable weight reduction than either drug alone, though individual responses vary based on metabolic factors and genetic predispositions
This regular testing allows your provider to monitor your body's response, track your progress in weight management, and ensure the medication remains safe for you over the long term
GLP-1s, she says, might have similar effects because most women with PCOS, their obesity is so tightly linked to insulin resistance, I think they benefit more than just the average person with obesity
Animal experiments and protocols conformed to the Guide for the Care and Use of Laboratory Animals (US National Institutes of Health), the Swiss animal protection laws and were approved by the Cantonal Veterinary Office in Zurich, Switzerland (study number 186/2017)
Researchers said while the risk is low, the rising use of GLP-1s in patients with and without Type 2 diabetes warrants special attention to medication safety